It matters little really, we all know EBITDA is meaningless as a metric. And managers with any financial integrity will spend more time explaining the cash generating performance of the business and metrics like ROIC or ROE for the period. i didn't once hear the CEO refer to EBITDA, which is pleasing!
I note the result included negligible warranty and service provisions despite the significant hike in revenue. Perhaps this is a symptom of "a seller's market" where the CEO indicated that terms and conditions of contracts are now more favourable in the current business environment??
- Forums
- ASX - By Stock
- Ann: 1HFY2023 Investor Presentation - Correction to EBITDA
It matters little really, we all know EBITDA is meaningless as a...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.61 |
Change
-0.890(7.74%) |
Mkt cap ! $421.6M |
Open | High | Low | Value | Volume |
$11.60 | $11.63 | $10.41 | $3.200M | 293.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 394 | $10.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.70 | 3500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 394 | 10.540 |
1 | 250 | 10.520 |
3 | 2345 | 10.510 |
1 | 10000 | 10.500 |
1 | 300 | 10.490 |
Price($) | Vol. | No. |
---|---|---|
10.700 | 3500 | 2 |
10.830 | 394 | 1 |
10.870 | 394 | 1 |
10.900 | 394 | 2 |
10.930 | 394 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
LYL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online